2011
DOI: 10.1002/ejoc.201100157
|View full text |Cite
|
Sign up to set email alerts
|

1,2,3‐Triazoles in Peptidomimetic Chemistry

Abstract: The ability to synthesise small peptidomimetics that mimic the secondary structure of proteins is an ever expanding area of research directed at sourcing new medicinal agents and biological probes. A significant current challenge is to mimic protein epitopes under physiological conditions using small peptidomimetics that are easy to prepare. The copper‐ and ruthenium‐catalysed Huisgen cycloaddition reactions provide such a general synthetic method, with the resulting 1,2,3‐triazoles being good peptide bond mim… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
175
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 267 publications
(180 citation statements)
references
References 86 publications
4
175
0
1
Order By: Relevance
“…While this ruthenium-catalyzed azide alkyne cycloaddition (RuAAC) has as yet not found as prevalent use as the CuAAC reaction, reports of its application are increasing rapidly. Although, the RuAAC reaction has been briefly mentioned in several reviews on triazole formation [13][14][15][16][17][18][19][20][21][22][23] and metalcatalyzed reactions, [24][25][26] by now a comprehensive survey focused solely on RuAAC is needed.…”
Section: Peptide Side-chain Mimeticsmentioning
confidence: 99%
“…While this ruthenium-catalyzed azide alkyne cycloaddition (RuAAC) has as yet not found as prevalent use as the CuAAC reaction, reports of its application are increasing rapidly. Although, the RuAAC reaction has been briefly mentioned in several reviews on triazole formation [13][14][15][16][17][18][19][20][21][22][23] and metalcatalyzed reactions, [24][25][26] by now a comprehensive survey focused solely on RuAAC is needed.…”
Section: Peptide Side-chain Mimeticsmentioning
confidence: 99%
“…These complexes catalyzed the regioselective RuAAC reaction of terminal alkynes forming, unlike CuAAC catalysts, 1,5-disubstituted 1,2,3-triazoles, and also unlike the CuAAC catalysts, they reacted with internal alkynes providing trisubstituted 1,2,3-triazoles [28,39,40,82]. The Cp*RuCl based catalysts provided multiple application that were recently developed (vide infra) [81,[83][84][85][86][87]. M a n u s c r i p t The first mechanistic investigation was proposed by Lin, Jia, Fokin and coworkers based on DFT calculations [39].…”
Section: The Ruaac Reactionsmentioning
confidence: 99%
“…Recent applications of Cp*RuCl-based catalysts included the synthesis of 4-haloisoxazoles and 5-halotriazoles [81], thiolactoside glycoclusters [83], one-step synthesis of triazoles [84], palladium-based metallocene complexes [85], 1,2,3-triazole peptides [86], 5-TTF-1,2,3-triazoles [87], 1,5-substitued 1,2,3-triazole amino acids [182], 5-amino-1,2,3-triazole-4-carboxylic acid [183a], and fluorinated 1,4,5-substituted 1,2,3-triazoles [183b]. RuAAC reactions catalyzed by Ru(II) complexes and RuNPs were also reported.…”
Section: Ruaacmentioning
confidence: 99%
“…Nowadays, the copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC, also known as the copper(I)-catalyzed Huisgen-Meldal-Sharpless cycloaddition) is the most widely used method for the synthesis of 1,4-disubstituted 1,2,3-triazoles from a wide range of organic azides and terminal alkynes [3][4][5][6][7]. Moreover, this process allows for the assembly of complex molecules, thus generating new unknown structures with an added potential biological and engineering value [8][9][10]. Monopropargyl pyrimidine nucleobases (uracil and thymine) are versatile building blocks for the synthesis of biologically relevant 1,2,3-triazoles [11].…”
Section: Introductionmentioning
confidence: 99%